310 related articles for article (PubMed ID: 33278850)
1. Incidence and outcome of SARS-CoV-2 infection on solid organ transplantation recipients: A nationwide population-based study.
Trapani S; Masiero L; Puoti F; Rota MC; Del Manso M; Lombardini L; Riccardo F; Amoroso A; Pezzotti P; Grossi PA; Brusaferro S; Cardillo M; ;
Am J Transplant; 2021 Jul; 21(7):2509-2521. PubMed ID: 33278850
[TBL] [Abstract][Full Text] [Related]
2. The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients.
Rendina M; Barone M; Lillo C; Trapani S; Masiero L; Trerotoli P; Puoti F; Lupo LG; Tandoi F; Agnes S; Grieco A; Andorno E; Marenco S; Giannini EG; Baccarani U; Toniutto P; Carraro A; Colecchia A; Cescon M; Morelli MC; Cillo U; Burra P; Angeli P; Colledan M; Fagiuoli S; De Carlis L; Belli L; De Simone P; Carrai P; Di Benedetto F; De Maria N; Ettorre GM; Giannelli V; Gruttadauria S; Volpes R; Corsale S; Mazzaferro V; Bhoori S; Romagnoli R; Martini S; Rossi G; Caccamo L; Donato MF; Rossi M; Ginanni Corradini S; Spada M; Maggiore G; Tisone G; Lenci I; Vennarecci G; Tortora R; Vivarelli M; Svegliati Baroni G; Zamboni F; Mameli L; Tafuri S; Simone S; Gesualdo L; Cardillo M; Di Leo A
Front Immunol; 2023; 14():1203854. PubMed ID: 37469512
[TBL] [Abstract][Full Text] [Related]
3. Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation-A Danish nationwide cohort study.
Overvad M; Koch A; Jespersen B; Gustafsson F; Krause TG; Hansen CH; Ethelberg S; Obel N
Am J Transplant; 2022 Nov; 22(11):2627-2636. PubMed ID: 35801493
[TBL] [Abstract][Full Text] [Related]
4. Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
Busà R; Russelli G; Miele M; Sorrentino MC; Di Bella M; Timoneri F; Di Mento G; Mularoni A; Vitulo P; Conaldi PG; Bulati M
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298854
[TBL] [Abstract][Full Text] [Related]
5. Quantifying excess deaths among solid organ transplant recipients in the COVID-19 era.
Massie AB; Werbel WA; Avery RK; Po-Yu Chiang T; Snyder JJ; Segev DL
Am J Transplant; 2022 Aug; 22(8):2077-2082. PubMed ID: 35294799
[TBL] [Abstract][Full Text] [Related]
6. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Outcomes and Vaccinations in Swedish Solid Organ Transplant Recipients 2020-2021: A Nationwide Multi-Register Comparative Cohort Study.
Søfteland JM; Li H; Magnusson JM; Leach S; Friman V; Gisslén M; Felldin M; Schult A; Karason K; Baid-Agrawal S; Wallquist C; Nyberg F
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400046
[TBL] [Abstract][Full Text] [Related]
8. Risk of Severe COVID-19 and Protective Effectiveness of Vaccination Among Solid Organ Transplant Recipients.
Huh K; Kang M; Kim YE; Choi Y; An SJ; Seong J; Go MJ; Kang JM; Jung J
J Infect Dis; 2024 Apr; 229(4):1026-1034. PubMed ID: 38097377
[TBL] [Abstract][Full Text] [Related]
9. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.
Subramanian V
J Infect Dis; 2023 Aug; 228(Suppl 1):S34-S45. PubMed ID: 37539762
[TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients.
Aslam S; Adler E; Mekeel K; Little SJ
Transpl Infect Dis; 2021 Oct; 23(5):e13705. PubMed ID: 34324256
[TBL] [Abstract][Full Text] [Related]
12. Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave.
Al Jurdi A; Morena L; Cote M; Bethea E; Azzi J; Riella LV
Am J Transplant; 2022 Dec; 22(12):3130-3136. PubMed ID: 35727916
[TBL] [Abstract][Full Text] [Related]
13. Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls.
Søfteland JM; Gisslén M; Liljeqvist JÅ; Friman V; de Coursey E; Karason K; Ekelund J; Felldin M; Magnusson J; Baid-Agrawal S; Wallquist C; Schult A; Jacobsson H; Bergdahl A; Bemark M; Andersson LM; Holm Gunnarsson I; Stenström J; Leach S
Am J Transplant; 2022 Apr; 22(4):1245-1252. PubMed ID: 34860447
[TBL] [Abstract][Full Text] [Related]
14. ARDS in solid organ transplant recipients hospitalized for COVID-19 based on the 2023 new definition.
Tang J; Zhou Y; Gong L; Deng J; Yuan Y; Zhong Y; Li J; Wang G
Heart Lung; 2024; 66():103-107. PubMed ID: 38604053
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch.
Yetmar ZA; Beam E; O'Horo JC; Seville MT; Brumble L; Ganesh R; Razonable RR
Transpl Infect Dis; 2022 Aug; 24(4):e13901. PubMed ID: 35848574
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients.
Aslam S; Liu J; Sigler R; Syed RR; Tu XM; Little SJ; De Gruttola V
Transpl Infect Dis; 2022 Apr; 24(2):e13788. PubMed ID: 34989104
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high-risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves.
Zeitler K; Piccicacco N; O'Neal M; Montero J; Myers A; Strebig D; Nestler S; Anger LB; Kim K
Transpl Infect Dis; 2023 Aug; 25(4):e14095. PubMed ID: 37378536
[TBL] [Abstract][Full Text] [Related]
18. Incidence and severity of SARS-CoV-2 infections in liver and kidney transplant recipients in the post-vaccination era: Real-life data from Denmark.
Hamm SR; Rezahosseini O; Møller DL; Loft JA; Poulsen JR; Knudsen JD; Pedersen MS; Schønning K; Harboe ZB; Rasmussen A; Sørensen SS; Nielsen SD
Am J Transplant; 2022 Nov; 22(11):2637-2650. PubMed ID: 35801693
[TBL] [Abstract][Full Text] [Related]
19. Incidence and Mortality of Emergency General Surgery Conditions Among Solid Organ Transplant Recipients in Ontario, Canada: A Population-based Analysis.
Gomez D; Acuna SA; Joseph Kim S; Nantais J; Santiago R; Calzavara A; Saskin R; Baxter NN
Transplantation; 2023 Mar; 107(3):753-761. PubMed ID: 36117253
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients.
Mrzljak A; Jureković Ž; Pavičić-Šarić J; Stevanović V; Tabain I; Hruškar Ž; Mikulić D; Barbić L; Vilibić-Čavlek T
Biochem Med (Zagreb); 2021 Oct; 31(3):030901. PubMed ID: 34658649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
